Evidence map›Paper›PMID 24753739›Full record

ReviewInternational journal of clinical and experimental medicine2014

The efficacy of Yunnan Baiyao on haemostasis and antiulcer: a systematic review and meta-analysis of randomized controlled trials.

Bo Yang, Zhe-Qi Xu, Hao Zhang, Feng-Ying Xu, Xue-Yin Shi, Zui Zou, Chang-Quan Ling, Ling Tang

Open access · greenAbstract readReview
In one paragraph

Review in International journal of clinical and experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Effects of Yunnan Baiyao on the Differentiation of HPDLFs on the Bio-OssInternational journal of general medicine · 2022
    Article
  9. Article
  10. Article
  11. Experimental Evaluation of Tranexamic Acid-Loaded Porous Starch as a Hemostatic Powder.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bo YangKidney Institute of CPLA, Division of Nephrology, Changzheng Hospital, Second Military Medical University Shanghai 200003, China.
Zhe-Qi XuNo. 9 Cadets Company, Graduate Administration Division; Second Military Medical University Shanghai 200433, China.
Hao ZhangDepartment of Anesthesiology, Changzheng Hospital, Second Military Medical University Shanghai 200003, China.
Feng-Ying XuDepartment of Anesthesiology, Changzheng Hospital, Second Military Medical University Shanghai 200003, China.
Xue-Yin ShiDepartment of Anesthesiology, Changzheng Hospital, Second Military Medical University Shanghai 200003, China.
Zui ZouDepartment of Anesthesiology, Changzheng Hospital, Second Military Medical University Shanghai 200003, China.
Chang-Quan LingDepartment of Traditional Chinese Medicine, Changhai Hospital Second Military Medical University Shanghai 200433, China.
Ling TangDepartment of Traditional Chinese Medicine, Changhai Hospital Second Military Medical University Shanghai 200433, China.
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Yunnan Baiyao (YNBY) is widely used to treat rhexis haemorrhage and ulcer in China. This meta-analysis was conducted to determine the efficacy of YNBY on local haemostasis and antiulcer. Randomized controlled trials were included on condition that assessing the effects of YNBY with/without routine drugs versus the same routine drugs on haemorrhage or ulcer after searching major databases. Data were validated, extracted and synthesized using relative risk (RR) for dichotomous data using random effects models. Fifty-five studies involving 5,150 patients were identified. (1) YNBY alone for haemorrhage (RR = 1.16; 95% CI 1.06 to 1.28) (2) YNBY alone for antiulcer (RR = 1.26; 95% CI 1.03 to 1.53). We found certain effects on ulcerative colitis (RR = 1.22) and skin ulcer (RR = 1.20) in subgroup analysis. (3) YNBY plus routine haemostatic drugs for haemorrhage (RR = 1.23; 95% CI 1.17 to 1.29) with a significant funnel plot asymmetry (Begg's test, p = 0). (4) YNBY plus routine antiulcer drugs for antiulcer (RR = 1.18; 95% CI 1.05 to 1.33). Treatment effect in the 2(nd) and 4(th) group was unstable when RCTs at high risk of bias were excluded. Great heterogeneities and possible publication bias were found among the trials which preclude certain conclusions. The existing data showed that YNBY alone was helpful in treating uterine haemorrhage, ulcerative colitis and skin ulcer. YNBY plus routine antiulcer drugs was more effective in treating ulcerative colitis versus antiulcer drugs alone.

Indexed as

haemorrhagemeta-analysisulcerYunnan Baiyao

Identifiers

PMID24753739
PMCPMC3992384
OpenAlexW1554845930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.